Sources: Shanghai-based Anew Labs, a ByteDance spinoff using AI for drug discovery, raised $290M from HSG, IDG Capital, and others at a $1.5B valuation (Kane Wu/Reuters)
Techmemeen

Kane Wu / Reuters : Sources: Shanghai-based Anew Labs, a ByteDance spinoff using AI for drug discovery, raised $290M from HSG, IDG Capital, and others at a $1.5B valuation — Chinese social media and internet company ByteDance has completed a $290 million fundraising for its AI drugmaking unit after spinning …
This is a short summary published by AI Global Wire. The full article is owned and hosted by Techmeme — open it there to read it in full.
Read the full story at Techmeme- Företag
Related AI news
- Intel-backed chipmaker Altera confidentially files for US IPOTech in Asia · September 16, 2026
- Sources: investors recently approached OpenAI with a proposal to invest at a $1.2T valuation, but OpenAI believes its value should be at least $1.5T (Sri Muppidi/New York Times)Techmeme · September 16, 2026
- TypeSafe AI debuts Jev, a model using "Reinforcement Learning for Calibrated Decisions" to produce typed probabilistic decisions that software can use directly (Thomas Claburn/The Register)Techmeme · September 16, 2026
- Samsung backs Dutch AI chip startup Euclyd in US$230M funding roundDIGITIMES · September 16, 2026
- Kepler bets HBM can scale without EUV — chip giants are buying inDIGITIMES · September 16, 2026
- Altera confidentially files for US IPO as AI chip demand fuels listing boomDIGITIMES · September 16, 2026